Publication:
The international prognostic index (IPI) prior to transplant is an important risk factor in patients receiving allogeneic stem cell transplantation for treatment of relapsed aggressive lymphoma

Simple item page
dc.bibliographiccitation.journalAnnals of Oncology
dc.bibliographiccitation.volume16
dc.contributor.authorGlass, Bertram
dc.contributor.authorWulf, Gerald
dc.contributor.authorHasenkamp, J.
dc.contributor.authorJung, Werner
dc.contributor.authorTruemper, Lorenz H.
dc.contributor.authorSchmitz, Norbert
dc.date.accessioned2018-11-07T10:17:38Z
dc.date.available2018-11-07T10:17:38Z
dc.date.issued2005
dc.format.extent99
dc.identifier.isi000233670100212
dc.identifier.urihttps://resolver.sub.uni-goettingen.de/purl?gro-2/41268
dc.notes.statuszu prüfen
dc.notes.submitterNajko
dc.publisherOxford Univ Press
dc.publisher.placeOxford
dc.relation.conference9th International Conference on Malignant Lymphoma
dc.relation.eventlocationLugano, SWITZERLAND
dc.relation.issn0923-7534
dc.titleThe international prognostic index (IPI) prior to transplant is an important risk factor in patients receiving allogeneic stem cell transplantation for treatment of relapsed aggressive lymphoma
dc.typeconference_abstract
dc.type.internalPublicationyes
dc.type.peerReviewedyes
dc.type.statuspublished
dspace.entity.typePublication

Files

Collections

Publications